The in vitro digestibility of alcalase enzymatic hydrolysates of β-conglycinin was studied. The results showed that the zeta potentials of β-conglycinin hydrolysates decreased and their electronegativity increased w...The in vitro digestibility of alcalase enzymatic hydrolysates of β-conglycinin was studied. The results showed that the zeta potentials of β-conglycinin hydrolysates decreased and their electronegativity increased when digested with pepsin and trypsin. Furthermore, the content of peptides with molecular weight from 10 kDa to 20 kDa remained stable, while those with higher molecular weight （〉20 kDa） decreased, and those with lower molecular weight （〈10 kDa） increased. The proportion of highly hydrophobic peptides decreased in the process of the in vitro digestion, but no significant change in the surface hydrophobicity indices of digestion products was observed （P 〈 0.05）. These results indicate that the β-conglycinin hydrolysates were degraded through in vitro digestion, but the degree of degradation was relatively low. Peptides with molecular weight from 10 kDa to 20 kDa in the β-conglycinin hydrolysates resisted the digestion by pepsin and trypsin and they remained stable during the in vitro digestion processes.展开更多
建立高脂小鼠模型,以辛伐他汀和市售醋蛋液水解物作为药品和食品阳性对照组,综合评价肽酶433P酶解蛋清获得蛋清水解物(egg white hydrolysate,EWH)的体内降血脂效果。结果表明,EWH可以显著抑制小鼠体质量增长,调节血脂异常,减轻肝脏脂...建立高脂小鼠模型,以辛伐他汀和市售醋蛋液水解物作为药品和食品阳性对照组,综合评价肽酶433P酶解蛋清获得蛋清水解物(egg white hydrolysate,EWH)的体内降血脂效果。结果表明,EWH可以显著抑制小鼠体质量增长,调节血脂异常,减轻肝脏脂质异常与炎症损伤,抑制肝脏脂肪细胞的积累、变性和脂肪组织甘油三酯的堆积。之后研究了胃肠消化对EWH血脂调节活性影响,结果发现,经胃肠消化后EWH的胆固醇胶束溶解度抑制率下降,但胆汁酸结合率和胰脂肪酶抑制率基本无明显变化。最后通过质谱鉴定及分子对接,得到了3个潜在的胰脂肪酶抑制活性肽,其氨基酸序列分别为LWVPSVY、YPILPEYLQ和WNIPIGTL,上述肽段可以通过氢键、疏水相互作用和静电相互作用等作用力与受体蛋白1ETH相互作用,从而发挥降血脂作用。展开更多
基金the financial support from the National Natural Science Foundation of China(No.30972046)the National Key Technologies Research and Development Program(No.2012BAD34B04)
文摘The in vitro digestibility of alcalase enzymatic hydrolysates of β-conglycinin was studied. The results showed that the zeta potentials of β-conglycinin hydrolysates decreased and their electronegativity increased when digested with pepsin and trypsin. Furthermore, the content of peptides with molecular weight from 10 kDa to 20 kDa remained stable, while those with higher molecular weight （〉20 kDa） decreased, and those with lower molecular weight （〈10 kDa） increased. The proportion of highly hydrophobic peptides decreased in the process of the in vitro digestion, but no significant change in the surface hydrophobicity indices of digestion products was observed （P 〈 0.05）. These results indicate that the β-conglycinin hydrolysates were degraded through in vitro digestion, but the degree of degradation was relatively low. Peptides with molecular weight from 10 kDa to 20 kDa in the β-conglycinin hydrolysates resisted the digestion by pepsin and trypsin and they remained stable during the in vitro digestion processes.
文摘建立高脂小鼠模型,以辛伐他汀和市售醋蛋液水解物作为药品和食品阳性对照组,综合评价肽酶433P酶解蛋清获得蛋清水解物(egg white hydrolysate,EWH)的体内降血脂效果。结果表明,EWH可以显著抑制小鼠体质量增长,调节血脂异常,减轻肝脏脂质异常与炎症损伤,抑制肝脏脂肪细胞的积累、变性和脂肪组织甘油三酯的堆积。之后研究了胃肠消化对EWH血脂调节活性影响,结果发现,经胃肠消化后EWH的胆固醇胶束溶解度抑制率下降,但胆汁酸结合率和胰脂肪酶抑制率基本无明显变化。最后通过质谱鉴定及分子对接,得到了3个潜在的胰脂肪酶抑制活性肽,其氨基酸序列分别为LWVPSVY、YPILPEYLQ和WNIPIGTL,上述肽段可以通过氢键、疏水相互作用和静电相互作用等作用力与受体蛋白1ETH相互作用,从而发挥降血脂作用。
